Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
T cell vaccination in multiple sclerosis: results of a preliminary study.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
Major stressful life events in adulthood and risk of multiple sclerosis.
Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients
Recommendations for the management of multiple sclerosis relapses.
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
Abstracts of ECTRIMS (Congress of the European Committee for Treatment and Research in Multiple Sclerosis) 2013. October 2-5, 2013. Copenhagen, Denmark.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
Neuromuscular taping in multiple sclerosis. A pilot study.
Clinically isolated syndromes and the relationship to multiple sclerosis.
Emerging roles of exosomes in neuron-glia communication.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Response to disease modifying therapies in African Americans with multiple sclerosis.
The use of aminopyridines in neurological disorders.
Prevalence of stress urinary incontinence in women with multiple sclerosis.
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »